References
- Paromov V, Suntres Z, Smith M, et al. Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy. J Burns Wounds 2007;30:e7
- Reports of specialists appointed by the Secretary General to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons. New York, NY: Security Council of the United Nations, 1986; Document S/16433
- Somani S, Babu. S. Toxicodynamics of sulfur mustard. Int J Clin Pharmacol Ther Toxicol 1989;27:419–435
- Ghanei M, Akbari Moqadam F, Mir Mohammad M, et al. Tracheobronchomalacia and Air Trapping after Mustard Gas Exposure. Am J Respir Crit Care Med 2006;173:304–309
- Ghanei M, Aslani J, Khateri S, et al. Public health status of the civil population of Sardasht 15 years following large-scale war time exposure to sulfur mustard. J Burns Surgical Wound Care 2003;2:7--18
- Hefazi M, Attaran D, Mahmoudi M, et al. Late respiratory complications of mustard gas poisoning in Iranian veterans. Inhal Toxicol 2005;17:587–592
- Thomason JWW, Rice TW, Milstone AP. Bronchiolitis obliterans in a survivor of a chemical weapons attack. JAMA 2003;290:598–599
- Ghanei M, Mokhtari M, Mohammad MM, et al. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol 2004;52:164–169
- Ghanei M, Shohrati M, Jafari M, et al. N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test. Basic Clin Pharmacol Toxicol 2008;103:428–432
- Toews G B. Impact of bacterial infections on airway diseases. Eur Respiratory Rev 2005;14:62–68
- Greene LS. Asthma, oxidant stress, and diet. Nutrition 1999;15:899–907
- Madill J, Aghdassi E, Arendt B, et al. Lung transplantation: does oxidative stress contribute to the development of bronchiolitis obliterans syndrome? Transplant Rev 2009;23:103–110
- James RW, Deakin SP. The importance of high-density lipoproteins forparaoxonase-1 secretion, stability and activity. Free Radic Biol Med 2004;37:1986–1994
- Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:473–480
- Marchesani M, Hakkarainen A, Tuomainen TP, et al. New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men. J Natl Cancer Inst 2003;95:812–818
- Akgur SA, Ozturk P, Solak I, et al. Human serumparaoxonase (PON1) activity in acute organophosphorus insecticide poisoning. Forensic Sci Int 2003;133:136–140
- Goswami B, Tayal D, Gupta N, et al. Paraoxonase: a multifaceted biomolecule. Clin Chim Acta 2009;410:1–12
- La Du B. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1988;43:227–229
- Adkins S, Gan KN, Mody M, et al. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 1993;52:598–608
- Deakin SP, James RW. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci (Lond) 2004;107:435–447
- Aviram M, Hardak E, Vaya J, et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000;101:2510–2517
- Rodrigo L, Hernandez AF, Lopez-CaBALlero JJ, et al. Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem Biol Interact 2001;137:123–137
- American Thoracic Society, Spirometric Classification (document on the internet)
- Golmanesh L, Mehrani H, Tabei M. Simple procedures for purification and stabilization of human serum paraoxonase-1. BiochemBiophys Methods 2008;70:1037–1042
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
- Jiang L, He L, Fountoulakis M. Comparison of protein precipitation methods for sample preparation prior to proteomic analysis. J Chromatogr A 2004;1023:317–320
- Mehrani H, Ghanei M, Aslani J, Golmanesh L. Bronchoalveolar lavage fluid proteomic patterns of sulfur mustard-exposed patients. Proteomics Clin Appl 2009;3:1191–1200
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254
- Ghanei M, Harandi AA. Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard (review). Inhal Toxicol 2011;23:363–371
- Shohrati M, Ghanei M, Shamspour N, et al. Activity and function in lung injuries due to sulphurmustard. Biomarkers 2008;13:728–733
- Jafari M, Ghanei M. Evaluation of plasma, erythrocytes, and bronchoalveolar lavage fluid antioxidant defense system in sulfur mustard-injured patients. Clin Toxicol (Phila) 2010;48:184–192
- Shohrati M, Ghanei M, et al. Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 2010;188:77–83
- Uzun H, Yanardag H, Gelisgen R, et al. Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis. Curr Med Res Opin 2008;6:1651–1657
- Lüersen K, Schmelzer C, Boesch-Saadatmandi C, et al. Paraoxonase 1 polymorphism Q192R affects the pro-inflammatory cytokine TNF-alpha in healthy males. BMC Res Notes 2011;4:141--146
- Deakin SP, Bioletto S, Bochaton-Piallat M-L, James RW. AHDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress. Free Radic Biol Med 2011;50:102–109
- Lgyesi G, Molnar V, Semsei A, et al. Gene expression profiling of experimental asthma reveals a possible role of paraoxonase-1 in the disease. Int Immunol 2009;21:967–975
- Selek S, Cosar N, Kocyigit A, et al. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Clin Biochem 2008;41:140–144
- Tekes S, Isik B, Yildiz T, et al. Chronic obstructive pulmonary disease and paraoxonase-1 192 and 55 gene. Biotechnology 2010;1:1644–1647
- Aksoy-Sagirli P, Cakmakoglu B, Isbir T, et al. Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population. Anticancer Res 2011;31:2225–2229
- Seo T, Pahwa P, McDuffie HH, et al. Effect of paraoxonase-1 Q192R polymorphism and smoking history on the long function decline in grain workers. Ann Epidemiol 2008;4:330–334
- Lee CH, Lee KY, Choe KH, et al. Effects of oxidative DNA damage induced by polycyclic aromatic hydrocarbons and genetic polymorphism of the paraoxonase-1 (PON1) gene on lung cancer. J Prev Med Public Health 2005;3:345–350
- Mackness B, Beltran-Debon R, Aragones G, et al. Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB life 2010;6:480–482